A Study of Apabetalone in Subjects With Long -COVID
NCT06590324
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
RECRUITING
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Post-Acute COVID-19 Syndrome
Interventions
DRUG:
Apabetalone
Sponsor
Resverlogix Corp